The skin care and treatment market in China, in terms of revenue, is expected to grow by 9.9 percent annually through 2029, according to the latest estimates. Skin care is essential for maintaining skin health and preventing skin conditions. It helps to protect the skin from environmental factors, such as…
Global Clinical Trial Software Market
Clinical trial software is a type of software designed specifically for the management and execution of clinical trials. Clinical trials are medical research studies in which human participants are involved to evaluate the effectiveness, safety, and side effects of new drugs, medical devices, and treatments. Clinical trial software helps clinical research organizations and pharmaceutical companies to manage, track, and monitor all aspects of the clinical trial process, from recruiting participants and managing study data to monitoring adverse events and generating reports. Such software often contains modular functionalities that allow customized workflows and processes, depending on the requirements of the particular study. The analysis predicts the global clinical trial software market will grow from USD 1,061.0 million in 2022 to USD 2,385.4 million by 2029, achieving a compound annual growth rate (CAGR) of 12.27 percent.
This industry report offers market estimates of the global market, followed by a detailed analysis of the feature, delivery, end user, and region. The global market data on clinical trial software can be segmented by feature: EDC, eCOA & ePRO, econsent. The EDC segment was the largest contributor to the global clinical trial software market in 2022. Clinical trial software market is further segmented by delivery: on-premise, SaaS, web-based. According to the research, the web-based segment had the largest share in the global clinical trial software market. Based on end user, the clinical trial software market is segmented into: biotech and pharmaceutical companies, CROs, medical device companies, others. The CROs segment held the largest revenue share in 2022. On the basis of region, the clinical trial software market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Globally, North America made up the largest share of the clinical trial software market.
The global clinical trial software market is highly competitive. Key companies profiled in the report include BSI Business Systems Integration AG, Clario (combination of Bioclinica and ERT), Dassault Systemes SE, DATATRAK International Inc., Fortress Medical Systems LLC., IBM Corporation, IQVIA Holdings Inc., Laboratory Corp of America Holdings (LabCorp), Medrio Inc., OpenClinica LLC, Oracle Corporation, Parexel International Corporation, RealTime Software Solutions LLC, Reify Health Inc., Veeva Systems Inc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
• Get a detailed picture of the Global Clinical Trial Software Market
• Identify segments/areas to invest in over the forecast period in the Global Clinical Trial Software Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.
Global Clinical Trial Software Market - Report Scope
BSI Business Systems Integration AG, Clario (combination of Bioclinica and ERT), Dassault Systemes SE, DATATRAK International Inc., Fortress Medical Systems LLC., IBM Corporation, IQVIA Holdings Inc., Laboratory Corp of America Holdings (LabCorp), Medrio Inc., OpenClinica LLC, Oracle Corporation, Parexel International Corporation, RealTime Software Solutions LLC, Reify Health Inc., Veeva Systems Inc.
According to the latest research, the skin-related beauty market in China is estimated to increase at the rate of 10.1% each year in the period from 2023 to 2029. Skin-related beauty refers to the products and treatments aimed at improving the health, appearance, and overall condition of the skin. It…